Epidemiology and Blood Flow Surveillance of the Native Arteriovenous Fistula: A Review of the Recent Literature
Corresponding Author
K. R. Polkinghorne
Department of Nephrology, Monash Medical Center, Melbourne, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia.
Correspondence to: K. R. Polkinghorne, Department of Nephrology, Monash Medical Center, 246 Clayton Road, Clayton, Victoria 3168, Australia. email: [email protected]Search for more papers by this authorP. G. Kerr
Department of Nephrology, Monash Medical Center, Melbourne, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia.
Search for more papers by this authorCorresponding Author
K. R. Polkinghorne
Department of Nephrology, Monash Medical Center, Melbourne, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia.
Correspondence to: K. R. Polkinghorne, Department of Nephrology, Monash Medical Center, 246 Clayton Road, Clayton, Victoria 3168, Australia. email: [email protected]Search for more papers by this authorP. G. Kerr
Department of Nephrology, Monash Medical Center, Melbourne, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia.
Search for more papers by this authorAbstract
Vascular access placement is a key management issue for hemodialysis patients. Despite being well regarded as the access of first choice, the native arteriovenous fistula (AVF) remains underutilized in the United States. The first part of this review examines recent epidemiology studies addressing patient factors associated with the use of the synthetic arteriovenous graft as opposed to the native fistula. Female gender and older age are consistently associated with a higher frequency of graft use. Diabetes, peripheral vascular disease, and body mass index were associated with graft use in some but not all of the studies. Recent evidence also suggests an independent survival advantage for patients dialyzing via native fistulae especially for infection-related mortality. The second part reviews evidence surrounding the recommendations for blood flow surveillance of the native fistula. The hemodynamic features of the native fistula are examined and differences from synthetic grafts are highlighted. Clinical studies assessing the use of blood flow surveillance to prevent the sudden thrombosis of native fistulae are reviewed. Blood flow thresholds for further investigation are yet to be determined definitely for AVF and randomized studies should be performed to assesses the impact on AVF thrombosis rates.
References
- 1 III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2000; 37(1 suppl 1): S137–S181.
- 2 Sands J, Perry M. Where are all the AV fistulas? Semin Dial. 2002; 15(3): 146–148.
- 3 Ethier JH, Lindsay RM, Barre PE, Kappel JE, Carlisle EJ, Common A. Clinical practice guidelines for vascular access. Canadian Society of Nephrology. J Am Soc Nephrol. 1999; 10(suppl 13): S297–S305.
- 4 Woods JD, Turenne MN, Strawderman RL, Young EW, Hirth RA, Port FK, Held PJ. Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis. 1997; 30(1): 50–57.
- 5 Polkinghorne KR, Kerr PG. Vascular access. In: GR Russ, ed. ANZDATA Registry Report 2002. Adelaide: Australia and New Zealand Dialysis and Transplant Registry, 2003; 102–107.
- 6 Besarab A, Frinak S. Strategies for the prospective detection of access dysfunction. In: P Conlon, S Schwab, M Nicholson, eds. Hemodialysis Vascular Access: Practice and Problems. Oxford: Oxford University Press, 2000; 157–182.
- 7 Besarab A. Advances in end-stage renal diseases 2000: access monitoring methods. Blood Purif. 2000; 18(4): 255–259.
- 8 Blankestijn PJ, Smits JH. How to identify the haemodialysis access at risk of thrombosis? Are flow measurements the answer? Nephrol Dial Transplant. 1999; 14(5): 1068–1071.
- 9 Krivitski NM, Gantela S. Access flow measurement as a predictor of hemodialysis graft thrombosis: making clinical decisions. Semin Dial. 2001; 14(3): 181–185.
- 10 Lindsay RM, Leypoldt JK. Monitoring vascular access flow. Adv Ren Replace Ther. 1999; 6(3): 273–277.
- 11 Paulson WD. Blood flow surveillance of hemodialysis grafts and the dysfunction hypothesis. Semin Dial. 2001; 14(3): 175–180.
- 12 Polkinghorne KR, Kerr PG. Predicting vascular access failure: a collective review. Nephrology. 2002; 7: 170–176.
- 13 Hirth RA, Turenne MN, Woods JD, Young EW, Port FK, Pauly MV, Held PJ. Predictors of type of vascular access in hemodialysis patients. JAMA. 1996; 276(16): 1303–1308.
- 14 Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group. Kidney Int. 2000; 58(5): 2178–2185.
- 15 Sehgal AR, Silver MR, Covinsky KE, Coffin R, Cain JA. Use of standardized ratios to examine variability in hemodialysis vascular access across facilities. Medical Review Board of The Renal Network, Inc. Am J Kidney Dis. 2000; 35(2): 275–281.
- 16 Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000; 57(2): 639–645.
- 17 Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002; 61(1): 305–316.
- 18 Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladonato J, Rocco M, Lowrie EG, Owen WF Jr. National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol. 2002; 13(8): 2117–2124.
- 19 Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, Deierhoi MH, Robbin ML. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int. 2001; 60(5): 2013–2020.
- 20 Rodriguez JA, Lopez J, Cleries M, Vela E. Vascular access for hemodialysis—an epidemiological study of the Catalan Renal Registry. Nephrol Dial Transplant. 1999; 14(7): 1651–1657.
- 21 Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002; 61(6): 2266–2271.
- 22
De Almeida E,
Dias L,
De Sousa FT,
Mil-Homens MC,
Pataca I,
Prata MM.
Survival in haemodialysis: is there a role for vascular access?
Nephrol Dial Transplant.
1997; 12(4): 852.
10.1093/ndt/12.4.852a Google Scholar
- 23 Woods JD, Port FK. The impact of vascular access for hemodialysis on patient morbidity and mortality. Nephrol Dial Transplant. 1997; 12(4): 657–659.
- 24 Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001; 60(4): 1443–1451.
- 25 Klassen P, Reddan D, Frankenfield DL, Lowrie E, Szczech L, McClellan W, Rocco M, Coladonato J, Owen W. Type of vascular access and risk of death among hemodialysis patients: findings from HCFA's Clinical Performance Measures (CPM) project [abstract]. J Am Soc Nephrol. 2001; 12: 334A.
- 26 Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002; 62(2): 620–626.
- 27 Krivitski NM. Theory and validation of access flow measurement by dilution technique during hemodialysis. Kidney Int. 1995; 48(1): 244–250.
- 28 Krivitski NM. Novel method to measure access flow during hemodialysis by ultrasound velocity dilution technique. ASAIO J. 1995; 41(3): M741–M745.
- 29 Nichols WW, O'Rourke MF. Mcdonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 3rd ed. Philadelphia: Lea & Febiger, 1990; 12–53.
- 30 Schneditz D, Fan Z, Kaufman A, Levin NW. Stability of access resistance during hemodialysis [published erratum appears in in Nephrol Dial Transplant. 2002; 17:1539]. Nephrol Dial Transplant. 1998; 13(3): 739–744.
- 31 Polkinghorne KR, Atkins RC, Kerr PG. Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis. 2003; 41(1): 132–139.
- 32 DeSoto DJ, Ram SJ, Faiyaz R, Birk CG, Paulson WD. Hemodynamic reproducibility during blood flow measurements of hemodialysis synthetic grafts. Am J Kidney Dis. 2001; 37(4): 790–796.
- 33 Rehman SU, Pupim LB, Shyr Y, Hakim R, Ikizler TA. Intradialytic serial vascular access flow measurements. Am J Kidney Dis. 1999; 34(3): 471–477.
- 34 Agharazii M, Clouatre Y, Nolin L, Leblanc M. Variation of intra-access flow early and late into hemodialysis. ASAIO J. 2000; 46(4): 452–455.
- 35 Besarab A, Lubkowski T, Vu A, Aslam A, Frinak S. Effects of systemic hemodynamics on flow within vascular accesses used for hemodialysis. ASAIO J. 2001; 47(5): 501–506.
- 36 Tonelli M, Jindal K, Hirsch D, Taylor S, Kane C, Henbrey S. Screening for subclinical stenosis in native vessel arteriovenous fistulae. J Am Soc Nephrol. 2001; 12(8): 1729–1733.
- 37 Miranda CL, Sands JJ. Flow volumes as a predictor of hemodialysis access failure. J Vasc Technol. 1998; 22: 73–76.
- 38 Tonelli M, Hirsch D, Clark TW, Wile C, Mossop P, Marryatt J, Jindal K. Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty. J Am Soc Nephrol. 2002; 13(12): 2969–2973.
- 39 Sands JJ, Jabyac PA, Miranda CL, Kapsick BJ. Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO J. 1999; 45(3): 147–150.
- 40 Schwab SJ, Oliver MJ, Suhocki P, McCann R. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int. 2001; 59(1): 358–362.
- 41 McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int. 2001; 60(3): 1164–1172.
- 42 Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966; 275(20): 1089–1092.